Intestinal mucosal-immune interface

The intestinal mucosal-immune interface is a complex biological boundary where the gut microbiota, intestinal epithelial cells (IECs), and the host immune system interact to maintain physiological homeostasis (Belkaid & Hand, 2014, Cell). This interface is responsible for the induction of oral tolerance to harmless food antigens and commensal microbes while simultaneously orchestrating rapid immune responses against pathogenic threats (Mowat & Agace, 2014, Nature Reviews Immunology). The system relies on the physical barrier of the epithelium, biochemical signals like antimicrobial peptides, and specialized immune structures such as Peyer's patches (Thursby & Juge, 2017, Biochemical Journal). Dysregulation of this ecosystem, often characterized by dysbiosis and increased permeability, is a primary driver in the pathogenesis of inflammatory bowel diseases and systemic metabolic disorders (Glasser et al., 2022, Nature Reviews Gastroenterology & Hepatology). Pharmacological management focuses on modulating this interface through cytokine-targeted biologics, integrin inhibitors that prevent inflammatory cell recruitment, and microbiome-based therapies designed to restore ecological balance (Hasan & Yang, 2019, PeerJ). As a therapeutic target, it represents a multifaceted environment rather than a single molecular entity, requiring a systems-biology approach to drug development.

Other names

Gut-microbiota-immune axisIntestinal mucosal barrierGut-associated lymphoid tissue interfaceMicrobiome-host interfaceGastrointestinal immune ecosystem

Neutralization of pro-inflammatory cytokines (e.g., TNF-alpha), blockade of leukocyte trafficking via integrin inhibition, modulation of Janus kinase (JAK) signaling, restoration of microbial diversity, and enhancement of epithelial tight junction integrity.